Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody-Reference-Cited by-同舟云学术

Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody

Published:2002-04 Issue:2 Volume:16 Page:144-149
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:

Author:

Gonwa Thomas A,Mai Martin L,Smith Larry B Melton Douglas,Levy Marlon F,Goldstein Robert M,Klintmalm Goran B

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1399-0012.2002.1o078.x/fullpdf

Reference20 articles.

1. CECKA JM The U.N.O.S. Scientific Renal Transplant Registry

2. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors;KONING;European Multicenter Study Group Transplantation,1997

3. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation;MATAS;Transplantation,2000

4. Delayed graft function. risk factors and implications for renal allograft survival;OJO;Transplantation,1997

5. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection;SCHOSKES;Transplantation,1998

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function;Transplantation Proceedings;2023-09

2. Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients;Cochrane Database of Systematic Reviews;2022-11-16

3. Risk factors for delayed kidney graft function from a deseased donor;Transplantologiya. The Russian Journal of Transplantation;2022-09-14

4. Late‐onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti‐CMV prophylaxis required following late‐onset allograft rejection?;Clinical Transplantation;2021-03-23

5. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function;Kidney International Reports;2021-02